Maximizing The Value Of An Internal Audit Program In Pharmaceutical Quality Operations
By Jim Morris, IQS Consulting; and Peter Savin, Beyond GMP Compliance There are two recent developments in our industry that constitute a seismic change in the way pharmaceutical manufacturers are regulated and, consequently, define what we in industry need to do. Firstly, there have been significant staffing cuts within FDA and other government agencies. CDER […]